MMedication Read More LLY’s Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes StudyApril 19, 2026 Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1…